Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of HER-2/neu CEP 17 mutations at invasive bladder cancer.

Advances in experimental medicine and biology - 1 Jan 2003

Feil Gerhard, Krause F Steffen, Zumbraegel Andreas, Bichler Karl H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Chromosomes, Human, Pair 17
Share to Gene Expression Regulation, Neoplastic
Share to In Situ Hybridization, Fluorescence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Receptor, ErbB-2

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 15088898
DOI: 10.1007/978-1-4419-8889-8_7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Detection of HER-2/neu CEP 17 mutations at invasive bladder cancer.PMID 15088898Read ↗

Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysisSemantic proximity Read ↗

TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.Semantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

Advances in bladder cancer biology and therapy.Semantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.Semantic proximity Read ↗

Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.Semantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.